Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Astellas Pharma Global Development, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

Study of the Pharmacokinetics of Isavuconazole in Healthy Non-Elderly and Elderly Male and Female Subjects

Phase 1

Completed

Conditions: Healthy Volunteers
Pharmacokinetics of Isavuconazole
Safety and Tolerability in Elderly

Interventions: Drug: isavuconazole

First Posted Date: 2012-08-06

Last Posted Date: 2015-09-01

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 28

Registration Number: NCT01657890

Locations: 🇺🇸
Parexel International, Glendale, California, United States

Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Subjects

Phase 1

Completed

Conditions: Healthy Adult Volunteers
Pharmacokinetics of Isavuconazole
Pharmacokinetics of Dextromethorphan

Interventions: Drug: Isavuconazole
Drug: dextromethorphan

First Posted Date: 2012-07-27

Last Posted Date: 2015-02-23

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 24

Registration Number: NCT01651325

Locations: 🇺🇸
Parexel, Baltimore, Maryland, United States

A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients

Phase 2

Completed

Conditions: Metastatic Castration-Resistant Prostate Cancer

Interventions: Drug: enzalutamide
Drug: abiraterone acetate
Drug: prednisone

First Posted Date: 2012-07-26

Last Posted Date: 2024-12-10

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 60

Registration Number: NCT01650194

Locations: 🇺🇸
Site US2492 MD Anderson Cancer Ctr, Houston, Texas, United States

Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Atorvastatin

Phase 1

Completed

Conditions: Pharmacokinetics of Isavuconazole
Healthy Volunteers
Pharmacokinetics of Atorvastatin

Interventions: Drug: Isavuconazole
Drug: atorvastatin

First Posted Date: 2012-07-10

Last Posted Date: 2015-02-23

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 24

Registration Number: NCT01635946

Locations: 🇺🇸
Clinical Pharmacology of Miami, Miami, Florida, United States

Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion

Phase 1

Completed

Conditions: Healthy Volunteers
Pharmacokinetics of Isavuconazole
Pharmacokinetics of Bupropion

Interventions: Drug: Isavuconazole
Drug: bupropion hydrochloride

First Posted Date: 2012-07-10

Last Posted Date: 2015-09-01

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 24

Registration Number: NCT01635972

Locations: 🇺🇸
Clinical Pharmacology of Miami, Miami, Florida, United States

Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer

Phase 2

Completed

Conditions: CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction
CLDN18.2-positive Gastric Adenocarcinoma
CLDN18.2-positive Adenocarcinoma of Esophagus

Interventions: Drug: epirubicin
Drug: oxaliplatin
Drug: capecitabine
Drug: zolbetuximab

First Posted Date: 2012-06-28

Last Posted Date: 2025-06-15

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 252

Registration Number: NCT01630083

Locations: 🇧🇬
Site BUL004, Plovdiv, Bulgaria
🇧🇬
Site BUL001, Sofia, Bulgaria
🇧🇬
Site BUL003, Sofia, Bulgaria

and more 45 locations

A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)

Phase 3

Completed

Conditions: Coronary Artery Disease (CAD)

Interventions: Drug: Regadenoson
Procedure: Single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI)

First Posted Date: 2012-06-13

Last Posted Date: 2016-02-08

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 1147

Registration Number: NCT01618669

Locations: 🇺🇸
Mobile Heart Specialists, PC, Mobile, Alabama, United States
🇺🇸
Silicon Valley Medical Imaging, Fremont, California, United States
🇺🇸
Long Beach Memorial Medical Center, Long Beach, California, United States

and more 66 locations

Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Conditions: Metastatic Castration-Resistant Prostate Cancer

First Posted Date: 2012-05-28

Last Posted Date: 2017-02-17

Lead Sponsor: Astellas Pharma Global Development, Inc.

Registration Number: NCT01606982

Drug Interaction Study of Isavuconazole and Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone

Phase 1

Completed

Conditions: Pharmacokinetics of Isavuconazole
Pharmacokinetics of Ethinyl Estradiol and Norethindrone
Healthy Volunteers

Interventions: Drug: isavuconazole
Drug: Oral Contraceptive (ethinyl estradiol / norethindrone)

First Posted Date: 2012-05-15

Last Posted Date: 2012-07-16

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 24

Registration Number: NCT01597986

Locations: 🇺🇸
Clinical Pharmacology of Miami, Miami, Florida, United States

A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis

Phase 2

Completed

Conditions: Psoriasis

Interventions: Drug: ASKP1240
Drug: Placebo

First Posted Date: 2012-04-25

Last Posted Date: 2024-03-05

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 60

Registration Number: NCT01585233

Locations: 🇦🇺
Specialist Connect, Brisbane, Queensland, Australia
🇦🇺
CMAX, Adelaide, Victoria, Australia
🇦🇺
Epworth Hospital, Richmond, Victoria, Australia

and more 10 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy